Arkolith/Insider Trading/AXIM/Form 4

Schroeder Blake

DirectorAXIM BIOTECHNOLOGIES, INC. (AXIM) · full profile →Form 4 · filed Aug 26, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 22, 2022Conversion(C)854K$0.03$26K854K

Transaction Codes

C
Conversion of a derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001096906-22-002027) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML